{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T09:19:47Z","timestamp":1768555187859,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011039","name":"Swiss Centre for Applied Human Toxicology","doi-asserted-by":"publisher","award":["2021-2024"],"award-info":[{"award-number":["2021-2024"]}],"id":[{"id":"10.13039\/501100011039","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.toxlet.2025.02.009","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:07:41Z","timestamp":1740125261000},"page":"31-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery of non-steroidal aldo-keto reductase 1D1 inhibitors through automated screening and in vitro evaluation"],"prefix":"10.1016","volume":"406","author":[{"given":"Jacek","family":"K\u0229dzierski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rianne E.","family":"van Diest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien A.","family":"Allard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Odermatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Smie\u0161ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1-2","key":"10.1016\/j.toxlet.2025.02.009_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1014814924965","article-title":"Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, bia 2-093, and bia 2-024","volume":"27","author":"Ambr\u00f3sio","year":"2002","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.toxlet.2025.02.009_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111168","article-title":"Antifungal therapy with azoles and the syndrome of acquired mineralocorticoid excess","volume":"524","author":"Beck","year":"2021","journal-title":"Mol. Cell. Endocrinol."},{"issue":"8","key":"10.1016\/j.toxlet.2025.02.009_bib3","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1183\/09031936.93.05080982","article-title":"Bronchodilatory effect of inhaled zardaverine, a phosphodiesterase iii and iv inhibitor, in patients with asthma","volume":"5","author":"Brunnee","year":"1992","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.toxlet.2025.02.009_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-244X-12-47","article-title":"Carbamazepine treatment of bipolar disorder: a retrospective evaluation of naturalistic long-term outcomes","volume":"12","author":"Chen","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.toxlet.2025.02.009_bib5","unstructured":"Cosmetic ingredient database, accessed: Q3 2021.\u3008https:\/\/single-market-economy.ec.europa.eu\/sectors\/cosmetics\/cosmetic-ingredient-database_en\u3009."},{"key":"10.1016\/j.toxlet.2025.02.009_bib6","article-title":"The cortisol switch between vulnerability and resilience","volume":"29","author":"de Kloet","year":"2023","journal-title":"Mol. Psychiatry"},{"issue":"24","key":"10.1016\/j.toxlet.2025.02.009_bib7","doi-asserted-by":"crossref","first-page":"16830","DOI":"10.1074\/jbc.M801778200","article-title":"Crystal structure of human liver 4-3-ketosteroid 5-reductase (akr1d1) and implications for substrate binding and catalysis","volume":"283","author":"Di Costanzo","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"Pt 1","key":"10.1016\/j.toxlet.2025.02.009_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1258\/000456306775141803","article-title":"Analytical and physiological factors affecting the interpretation of serum testosterone concentration in men","volume":"43","author":"Diver","year":"2006","journal-title":"Ann. Clin. Biochem."},{"issue":"30","key":"10.1016\/j.toxlet.2025.02.009_bib9","doi-asserted-by":"crossref","first-page":"19786","DOI":"10.1074\/jbc.C109.016931","article-title":"Inhibition of human steroid 5-reductase (akr1d1) by finasteride and structure of the enzyme-inhibitor complex","volume":"284","author":"Drury","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"32","key":"10.1016\/j.toxlet.2025.02.009_bib10","doi-asserted-by":"crossref","first-page":"24529","DOI":"10.1074\/jbc.M110.127779","article-title":"Characterization of disease-related 5\u03b2 -reductase (AKR1D1) mutations reveals their potential to cause bile acid deficiency","volume":"285","author":"Drury","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.toxlet.2025.02.009_bib11","first-page":"600","article-title":"The regulation of endocrine-disrupting chemicals to minimize their impact on health, nature reviews","volume":"19","author":"Duh-Leong","year":"2023","journal-title":"Endocrinology"},{"issue":"51","key":"10.1016\/j.toxlet.2025.02.009_bib12","doi-asserted-by":"crossref","first-page":"13537","DOI":"10.1021\/bi801276h","article-title":"Crystal structures of human 4-3-ketosteroid 5-reductase (akr1d1) reveal the presence of an alternative binding site responsible for substrate inhibition","volume":"47","author":"Faucher","year":"2008","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.toxlet.2025.02.009_bib13","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.toxlet.2025.02.009_bib14","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2017-00025","article-title":"A reappraisal of testosterone\u2019s binding in circulation: Physiological and clinical implications","volume":"38","author":"Goldman","year":"2017","journal-title":"Endocr. Rev."},{"issue":"5","key":"10.1016\/j.toxlet.2025.02.009_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/medicina57050433","article-title":"Efficacy of carbamazepine and its derivatives in the treatment of bipolar disorder","volume":"57","author":"Grunze","year":"2021","journal-title":"Medicina"},{"issue":"1","key":"10.1016\/j.toxlet.2025.02.009_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1042\/BJ20140220","article-title":"Rate of steroid double-bond reduction catalysed by the human steroid 5-reductase (AKR1D1) is sensitive to steroid structure: implications for steroid metabolism and bile acid synthesis","volume":"462","author":"Jin","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.toxlet.2025.02.009_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2023.07.006","article-title":"Assessment of the inhibitory potential of anabolic steroids towards human akr1d1 by computational methods and in vitro evaluation","volume":"384","author":"K\u0229dzierski","year":"2023","journal-title":"Toxicol. Lett."},{"issue":"19","key":"10.1016\/j.toxlet.2025.02.009_bib18","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1093\/bioinformatics\/bts480","article-title":"Snakemake\u2014a scalable bioinformatics workflow engine","volume":"28","author":"K\u00f6ster","year":"2012","journal-title":"Bioinformatics"},{"issue":"10","key":"10.1016\/j.toxlet.2025.02.009_bib19","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1136\/gut.52.10.1494","article-title":"Mutations in srd5b1 (akr1d1), the gene encoding 4-3-oxosteroid 5-reductase, in hepatitis and liver failure in infancy","volume":"52","author":"Lemonde","year":"2003","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.toxlet.2025.02.009_bib20","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: improving force field accuracy on challenging regimes of chemical space","volume":"17","author":"Lu","year":"2021","journal-title":"J. Chem. Theory Comput."},{"issue":"1","key":"10.1016\/j.toxlet.2025.02.009_bib21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr. Rev."},{"issue":"24","key":"10.1016\/j.toxlet.2025.02.009_bib22","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1080\/10408398.2021.1903382","article-title":"Endocrine disrupting chemicals and breast cancer: a systematic review of epidemiological studies","volume":"62","author":"Murphy Lam Yim Wan","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.toxlet.2025.02.009_bib23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.metabol.2019.153947","article-title":"Akr1d1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease","volume":"99","author":"Nikolaou","year":"2019","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.toxlet.2025.02.009_bib24","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1080\/10408444.2021.2009438","article-title":"Edc-induced mechanisms of immunotoxicity: a systematic review","volume":"51","author":"Oscar Sabuz Vidal","year":"2021","journal-title":"Crit. Rev. Toxicol."},{"issue":"16","key":"10.1016\/j.toxlet.2025.02.009_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25168857","article-title":"5-dihydrosteroids: formation and properties","volume":"25","author":"Penning","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxlet.2025.02.009_bib26","unstructured":"Schr\u00f6dinger LLC New York NY, Schr\u00f6dinger Release 2021-3: Maestro (2021)."},{"issue":"1","key":"10.1016\/j.toxlet.2025.02.009_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0006-2952(91)90694-Z","article-title":"Zardaverine as a selective inhibitor of phosphodiesterase isozymes","volume":"42","author":"Schudt","year":"1991","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.toxlet.2025.02.009_bib28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13054-020-02915-5","article-title":"Revisited: therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics","volume":"24","author":"Schulz","year":"2020","journal-title":"Crit. Care"},{"issue":"12","key":"10.1016\/j.toxlet.2025.02.009_bib29","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: A software program for pKa prediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. -Aided Mol. Des."},{"key":"10.1016\/j.toxlet.2025.02.009_bib30","first-page":"bnae024","article-title":"The cortisol awakening response: regulation and functional significance","author":"Stalder","year":"2024","journal-title":"Endocr. Rev."},{"issue":"D1","key":"10.1016\/j.toxlet.2025.02.009_bib31","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the drugbank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427425000323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427425000323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T07:18:39Z","timestamp":1741591119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427425000323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":31,"alternative-id":["S0378427425000323"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2025.02.009","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of non-steroidal aldo-keto reductase 1D1 inhibitors through automated screening and in vitro evaluation","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2025.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}